ambossIconambossIcon

Seborrheic dermatitis

Last updated: December 4, 2024

Summarytoggle arrow icon

Seborrheic dermatitis is a common chronic inflammatory skin condition that affects areas with a high concentration of sebaceous glands (e.g., scalp, face). The etiology is unknown, but microbial colonization of the skin (esp. Malassezia species), hormonal and immunological factors, and climate have been implicated. Seborrheic dermatitis typically manifests as erythematous patches or plaques with overlying scaling or greasy yellow crusts. Symptoms include burning and/or itching. Diagnosis is clinical. Treatment typically begins with topical antifungal agents; depending on severity and areas of involvement, other topical and/or systemic anti-inflammatory agents may be used. Ongoing management of seborrheic dermatitis may include pharmacotherapy to prevent disease flares.

Infantile seborrheic dermatitis (cradle cap) is a subtype of seborrheic dermatitis that appears within the first 3 months after birth and often affects the scalp. Infantile seborrheic dermatitis usually resolves without intervention by 12 months of age.

Icon of a lock

Register or log in , in order to read the full article.

Epidemiologytoggle arrow icon

Epidemiological data refers to the US, unless otherwise specified.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

References:[4][5][6]

Icon of a lock

Register or log in , in order to read the full article.

Pathophysiologytoggle arrow icon

References:[4][5][6][7]

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

The following applies to adults and adolescents. See “Special patient groups” for features of infantile seborrheic dermatitis. [3][8]

Patients with dark skin tones may present with hypopigmentation, without erythema, and with less scaling than patients with light skin tones. [3]

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

  • Diagnosis is clinical. [8]
  • Diagnostic uncertainty: Obtain skin biopsy. [8]
  • Severe, extensive, and/or refractory disease: Consider evaluation for underlying medical conditions. [3][10]
Icon of a lock

Register or log in , in order to read the full article.

Differential diagnosestoggle arrow icon

The differential diagnoses listed here are not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Managementtoggle arrow icon

Goals of management are to reduce active lesions, mitigate symptoms, and prevent disease flares. [3][8]

Approach [3][8][16]

Exposure to sunlight reduces symptoms in some individuals and precipitates symptoms in others. [9]

Treatment of active seborrheic dermatitis [3][8][16]

Initial treatment

Initial topical therapy for seborrheic dermatitis [3][8][16]
Scalp Face and body
Antifungals
Corticosteroids

Topical antifungal therapy is the first-line treatment for seborrheic dermatitis affecting the scalp, face, and/or body. [8]

Topical corticosteroid use should be intermittent and limited to 2–4 weeks at a time to reduce the risk of adverse effects (e.g., atrophy, hypopigmentation). [8]

Treatment of refractory seborrheic dermatitis

Ongoing management of seborrheic dermatitis

Seborrheic dermatitis is a chronic disease; long-term management involves maintenance therapy to reduce the risk of disease flares and acute treatment as needed. [3][8]

Icon of a lock

Register or log in , in order to read the full article.

Complicationstoggle arrow icon

We list the most important complications. The selection is not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Prognosistoggle arrow icon

Seborrheic dermatitis often has a chronic, recurrent course with flares requiring intermittent treatment. [8]

Icon of a lock

Register or log in , in order to read the full article.

Special patient groupstoggle arrow icon

Infantile seborrheic dermatitis [2][8]

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer